Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

Expert

 

Washington Times on Vaccine Economics

Gilbert Ross in the Washington Times writes:

Pharmaceutical companies have fled the vaccine market in droves over the last 40 years. The research and development for vaccines is too expensive and the market too small for drug makers, contrary to the popular image of profit-raking pharmaceutical giants, and this is only worsening.

Ethical Issues Over AIDS Drug Trials

Act Up Paris is stalling trials of tenofovir in two African countries.

Agencies including the Bill & Melinda Gates Foundation, the Centers for Disease Control & Prevention and the National Institutes of Health are funding studies by more than a dozen research teams in seven countries to examine whether tenofovir, a drug already used by some people living with HIV to prevent the virus from spreading to uninfected cells, can be taken orally once daily to prevent people from contracting HIV.

An R&D Treaty and Medical Innovation Prize Fund

The Consumer Project on Technology (www.cptech.org) has proposed a Medical R&D Treaty. The aim is to replace trade agreements that focus on patents or drug prices with minimum national obligations for supporting medical R&D. There would be freedom for countries to decide for themselves how to fulfil their commitment to support R&D, using their chosen combination of intellectual property rules and patents, public funding, advance commitments, or open source collaborations.

An R&D Treaty and Medical Innovation Prize Fund

The Consumer Project on Technology (www.cptech.org) has proposed a Medical R&D Treaty. The aim is to replace trade agreements that focus on patents or drug prices with minimum national obligations for supporting medical R&D. There would be freedom for countries to decide for themselves how to fulfil their commitment to support R&D, using their chosen combination of intellectual property rules and patents, public funding, advance commitments, or open source collaborations.

More Detail from Gordon Brown

In today's Observer (the Sunday sister newspaper of the Guardian), Gordon Brown sets out his plan to fight disease.

Our focus will be a plan to support a new international platform for research into vaccines and cures, public-private partnerships and advance purchase schemes for their development and, finance, to build the capacity of health-care systems.

On advance purchase agreements, he says:

Brown Commitment on Vaccines

Gordon Brown announcing his plansGordon Brown made an important speech today setting out the UK's development agenda for the G8 meeting at Gleneagles.

It is an extraordinary fact that a finance facility for immunisation, raising an extra $4 billion ahead of 2015 for vaccinations, could save an extra 5 million lives over the next 10 years. In the years after 2015 another 5 million more lives could be saved.

Honduras Closer to MCA Vision

MCA watchers have been concerned about a seeming lack of civil society participation in proposal design in MCA-eligible countries. That participation is one of MCA's main objectives. Some observers claim that in some countries civil society contributes only at the periphery of the debate while the business community leads the process. Honduras may be different.

Pages